Frontier IP Group
FIPP · AIM · Industrial Goods and Services · mcap £14m today
All announcements
-
31 Jul 26Total Voting RightsRNS 9699361 ↗
-
28 Jul 26Portfolio news: Pulsiv agreement with Delta Matrix
Portfolio news - Pulsiv appoints Delta Matrix as exclusive manufacturing partner
RNS 9689970 ↗ -
23 Jul 26Holding(s) in CompanyRNS 9685093 ↗
-
22 Jul 26Portfolio news: CRI wins EU grant
Portfolio news - Cambridge Raman Imaging wins European grant and targets pharmaceutical control market
RNS 9680725 ↗ -
17 Jul 26Holding(s) in CompanyRNS 9675646 ↗
-
17 Jul 26Holding(s) in CompanyRNS 9675546 ↗
-
17 Jul 26Holding(s) in CompanyRNS 9675540 ↗
-
15 Jul 26Result of General Meeting & Total Voting RightsRNS 9670510 ↗
-
06 Jul 26InSignals Neurotech Grant
Portfolio news - InSignals Neurotech secures grant funding to expand remote monitoring and launch Parkinson's app
RNS 9653043 ↗ -
30 Jun 26Total Voting RightsRNS 9645353 ↗
-
26 Jun 26Holding(s) in CompanyRNS 9639229 ↗
-
25 Jun 26Holding(s) in CompanyRNS 9637469 ↗
-
25 Jun 26Holding(s) in CompanyRNS 9635423 ↗
-
24 Jun 26Portfolio news: Investment in Fieldwork Robotics
Portfolio news - SEED Innovations invests in Fieldwork Robotics
RNS 9633223 ↗ -
23 Jun 26Posting of Circular and Notice of General MeetingRNS 9630758 ↗
-
19 Jun 26Result of Retail Offer
Frontier IP Group plc (AIM: FIPP), a specialist in commercialising intellectual property, is pleased to announce that the Retail Offer, as announced at 5.20 p.m. on 16 June 2026 (the "Retail Launch Announcement"), has now closed.
RNS 9626423 ↗ -
17 Jun 26Result of Placing and Subscription
Frontier IP Group plc (AIM: FIPP), a specialist in commercialising intellectual property, is pleased to announce that further to the announcement made at 4.58 p.m. on 16 June 2026 (the "Launch Announcement"), the Placing has successfully closed at the...
RNS 9621822 ↗ -
16 Jun 26Retail Offer
THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY SHORE CAPITAL STOCKBROKERS LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT...
RNS 9621637 ↗ -
16 Jun 26Proposed Placing and Subscription
Proposed Placing and Subscription to raise, in aggregate, minimum gross proceeds of £4.0 million
RNS 9621598 ↗ -
26 May 26Portfolio news: Dekiln strategic partnership
Portfolio news - Dekiln to explore strategic partnership with Johnson Tiles
RNS 9584001 ↗ -
05 May 26Appointment of Chief Financial Officer New CFO
Frontier IP, a specialist in commercialising intellectual property, is pleased to announce the appointment of Shaun Claydon as Chief Financial Officer and Company Secretary with immediate effect.
RNS 9550763 ↗ -
16 Apr 26Holding(s) in CompanyRNS 9524541 ↗
-
15 Apr 26Portfolio News: 2D Photonics subsidiary grant
Portfolio News: 2D Photonics subsidiary granted €211 million in European Commission-approved state aid
RNS 9520479 ↗ -
13 Apr 26Holding(s) in CompanyRNS 9517560 ↗
-
10 Apr 26Update re Investee Company
Portfolio News: EU State Aid approval for Italian Government grant to CamGraPhic
RNS 9514889 ↗ -
08 Apr 26Portfolio news – Fieldwork Robotics £3M fundraise
Portfolio news - Fieldwork Robotics to scale up after raising £3 million in funding
RNS 9509211 ↗ -
31 Mar 26Holding(s) in CompanyRNS 9501579 ↗
-
30 Mar 26Unaudited Half Year Results
UNAUDITED HALF-YEAR RESULTS FOR THE SIX MONTHS TO 31 DECEMBER 2025
RNS 9497018 ↗ -
23 Mar 26Alusid reaches milestone in European roll out
Portfolio news - Alusid reaches milestone in European roll out with Tegelgroep Nederland agreement
RNS 9485835 ↗ -
28 Jan 26Holding(s) in CompanyRNS 9392155 ↗
-
19 Jan 26Portfolio news - Strong results for TVG vaccine
Portfolio news - Strong results for TVG vaccine against zoonotic pig disease Streptococcus suis
RNS 9364036 ↗ -
12 Jan 26Holding(s) in CompanyRNS 9347627 ↗
-
31 Dec 25Total Voting RightsRNS 9327653 ↗
-
31 Dec 25Result of AGMRNS 9327535 ↗
-
29 Dec 25Holding(s) in CompanyRNS 9322900 ↗
-
24 Dec 25Holding(s) in CompanyRNS 9318044 ↗
-
24 Dec 25Holding(s) in CompanyRNS 9316808 ↗
-
23 Dec 25Directors’ Shareholdings
Frontier IP Group plc (AIM: FIPP), a specialist in commercialising intellectual property, confirms that, further to the announcement released on 22 December 2025 on the closing of the Retail Offer, the shareholdings of the Directors following their...
RNS 9316089 ↗ -
22 Dec 25Result of Retail Offer
Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announced on 17 December 2025 the launch of a fundraising comprising a Placing and Subscription in conjunction with a Retail Offer.
RNS 9313620 ↗ -
18 Dec 25Dekiln benefits from £3 million funding
Portfolio news - Dekiln benefits from £3 million funding from the Royal Academy of Engineering to scale up to industrial production
RNS 9306251 ↗ -
17 Dec 25Result of Placing and Subscription
Frontier IP Group plc (AIM: FIPP), a specialist in commercialising intellectual property, is pleased to announce that further to the announcement made at 7.00 a.m. today (the "Launch Announcement"), the Placing has successfully closed at the Issue Price of...
RNS 9303462 ↗ -
17 Dec 25Retail Offer
· Frontier IP announces a conditional retail offer of new Ordinary Shares via RetailBook.
RNS 9301862 ↗ -
17 Dec 25Proposed Placing and Subscription to raise £870k
Proposed Placing and Subscription to raise, in aggregate, gross proceeds
RNS 9301705 ↗ -
15 Dec 25Portfolio news- Alusid £500k pre-IPO funding round
Portfolio news - Alusid raises £500,000 through pre-IPO funding round
RNS 9295802 ↗ -
10 Dec 25Holding(s) in CompanyRNS 9288668 ↗
-
09 Dec 25Posting of Annual Report & Notice of AGMRNS 9283791 ↗
-
08 Dec 25
-
02 Dec 25Alusid signs Swedish distribution agreement
Portfolio news - Alusid signs third international distribution agreement with leading Swedish tile distributor Kakelspecialisten
RNS 9269192 ↗ -
06 Nov 25Bord Change
Frontier IP, a specialist in commercialising intellectual property, today announces that Chief Financial Officer Jo Stent is to leave the Group to pursue an opportunity with a private equity backed specialist financial services provider.
RNS 9215620 ↗ -
03 Nov 25TVG demonstrates success in animal trials
Portfolio news - The Vaccine Group demonstrates outstanding success in animal trials to address major global livestock disease
RNS 9207526 ↗ -
20 Oct 25Amprologix raises £740,000 in Pre-Series A round
Portfolio news - Amprologix raises £740,000 in pre-Series A funding round to accelerate development of novel antibiotics
RNS 9180451 ↗
Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.